The global market for Companion Diagnostics was estimated to be worth US$ 3971.9 million in 2023 and is forecast to a readjusted size of US$ 9608.1 million by 2030 with a CAGR of 13.2% during the forecast period 2024-2030

Companion Diagnostics - Market

A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.Digital Companion Diagnostics (CD) refer to a type of in vitro diagnostic tests or assays that are intended to help physicians in making effective treatment decisions based on the patient’s response to a specific drug targeted toward a specific biomarker, expressed in a particular disease or indication. The patient’s response to an ongoing therapy is mapped with the help of companion diagnostics in terms of changes in gene amplification, nullifying the effect of mutations, changes in protein overexpression and receptor-substrate interaction, and so on. These tests aim at providing insights into the patient’s likely response pattern to a particular therapy, thereby enabling optimization of appropriate dosing concentrations and course of administration. The increasing importance of personalized medicine and commercialization of targeted therapeutics have driven the demand for companion diagnostics, which in turn is projected to observe a rise in trend of adoption by patients as well as health care service providers.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Companion Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Companion Diagnostics by region & country, by Type, and by Application.

The Companion Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostics.

Market Segmentation

Scope of Companion Diagnostics - Market Report

Report Metric	Details
Report Name	Companion Diagnostics - Market
Forecasted market size in 2030	US$ 9608.1 million
CAGR	13.2%
Forecasted years	2024 - 2030
Segment by Type:	Polymerase Chain Reaction (PCR) Immunohistochemistry (IHC) In Situ Hybridization (ISH) Next Generation Sequencing (NGS)
Segment by Application	Hospitals Pharmaceutical Companies Laboratories Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Life Technologies, GE Healthcare, Agendia, Qiagen, Genomic Health, Myriad Genetics, Advanced Cell Diagnostics, Danaher, Applied Proteomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Companion Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Companion Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Companion Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Companion Diagnostics - Market size in 2030?

Ans: The Companion Diagnostics - Market size in 2030 will be US$ 9608.1 million.

Who are the main players in the Companion Diagnostics - Market report?

Ans: The main players in the Companion Diagnostics - Market are Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Life Technologies, GE Healthcare, Agendia, Qiagen, Genomic Health, Myriad Genetics, Advanced Cell Diagnostics, Danaher, Applied Proteomics

What are the Application segmentation covered in the Companion Diagnostics - Market report?

Ans: The Applications covered in the Companion Diagnostics - Market report are Hospitals, Pharmaceutical Companies, Laboratories, Other

What are the Type segmentation covered in the Companion Diagnostics - Market report?

Ans: The Types covered in the Companion Diagnostics - Market report are Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Next Generation Sequencing (NGS)

1 Market Overview

1.1 Companion Diagnostics Product Introduction

1.2 Global Companion Diagnostics Market Size Forecast

1.3 Companion Diagnostics Market Trends & Drivers

1.3.1 Companion Diagnostics Industry Trends

1.3.2 Companion Diagnostics Market Drivers & Opportunity

1.3.3 Companion Diagnostics Market Challenges

1.3.4 Companion Diagnostics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Companion Diagnostics Players Revenue Ranking (2023)

2.2 Global Companion Diagnostics Revenue by Company (2019-2024)

2.3 Key Companies Companion Diagnostics Manufacturing Base Distribution and Headquarters

2.4 Key Companies Companion Diagnostics Product Offered

2.5 Key Companies Time to Begin Mass Production of Companion Diagnostics

2.6 Companion Diagnostics Market Competitive Analysis

2.6.1 Companion Diagnostics Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Companion Diagnostics Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Polymerase Chain Reaction (PCR)

3.1.2 Immunohistochemistry (IHC)

3.1.3 In Situ Hybridization (ISH)

3.1.4 Next Generation Sequencing (NGS)

3.2 Global Companion Diagnostics Sales Value by Type

3.2.1 Global Companion Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Companion Diagnostics Sales Value, by Type (2019-2030)

3.2.3 Global Companion Diagnostics Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Pharmaceutical Companies

4.1.3 Laboratories

4.1.4 Other

4.2 Global Companion Diagnostics Sales Value by Application

4.2.1 Global Companion Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Companion Diagnostics Sales Value, by Application (2019-2030)

4.2.3 Global Companion Diagnostics Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Companion Diagnostics Sales Value by Region

5.1.1 Global Companion Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Companion Diagnostics Sales Value by Region (2019-2024)

5.1.3 Global Companion Diagnostics Sales Value by Region (2025-2030)

5.1.4 Global Companion Diagnostics Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Companion Diagnostics Sales Value, 2019-2030

5.2.2 North America Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Companion Diagnostics Sales Value, 2019-2030

5.3.2 Europe Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Companion Diagnostics Sales Value, 2019-2030

5.4.2 Asia Pacific Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Companion Diagnostics Sales Value, 2019-2030

5.5.2 South America Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Companion Diagnostics Sales Value, 2019-2030

5.6.2 Middle East & Africa Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Companion Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Companion Diagnostics Sales Value

6.3 United States

6.3.1 United States Companion Diagnostics Sales Value, 2019-2030

6.3.2 United States Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Companion Diagnostics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Companion Diagnostics Sales Value, 2019-2030

6.4.2 Europe Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Companion Diagnostics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Companion Diagnostics Sales Value, 2019-2030

6.5.2 China Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Companion Diagnostics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Companion Diagnostics Sales Value, 2019-2030

6.6.2 Japan Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Companion Diagnostics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Companion Diagnostics Sales Value, 2019-2030

6.7.2 South Korea Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Companion Diagnostics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Companion Diagnostics Sales Value, 2019-2030

6.8.2 Southeast Asia Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Companion Diagnostics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Companion Diagnostics Sales Value, 2019-2030

6.9.2 India Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Companion Diagnostics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Roche Holdings

7.1.1 Roche Holdings Profile

7.1.2 Roche Holdings Main Business

7.1.3 Roche Holdings Companion Diagnostics Products, Services and Solutions

7.1.4 Roche Holdings Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.1.5 Roche Holdings Recent Developments

7.2 Abbott Laboratories

7.2.1 Abbott Laboratories Profile

7.2.2 Abbott Laboratories Main Business

7.2.3 Abbott Laboratories Companion Diagnostics Products, Services and Solutions

7.2.4 Abbott Laboratories Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.2.5 Abbott Laboratories Recent Developments

7.3 Thermo Fisher Scientific

7.3.1 Thermo Fisher Scientific Profile

7.3.2 Thermo Fisher Scientific Main Business

7.3.3 Thermo Fisher Scientific Companion Diagnostics Products, Services and Solutions

7.3.4 Thermo Fisher Scientific Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.3.5 Agilent Technologies Recent Developments

7.4 Agilent Technologies

7.4.1 Agilent Technologies Profile

7.4.2 Agilent Technologies Main Business

7.4.3 Agilent Technologies Companion Diagnostics Products, Services and Solutions

7.4.4 Agilent Technologies Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.4.5 Agilent Technologies Recent Developments

7.5 Life Technologies

7.5.1 Life Technologies Profile

7.5.2 Life Technologies Main Business

7.5.3 Life Technologies Companion Diagnostics Products, Services and Solutions

7.5.4 Life Technologies Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.5.5 Life Technologies Recent Developments

7.6 GE Healthcare

7.6.1 GE Healthcare Profile

7.6.2 GE Healthcare Main Business

7.6.3 GE Healthcare Companion Diagnostics Products, Services and Solutions

7.6.4 GE Healthcare Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.6.5 GE Healthcare Recent Developments

7.7 Agendia

7.7.1 Agendia Profile

7.7.2 Agendia Main Business

7.7.3 Agendia Companion Diagnostics Products, Services and Solutions

7.7.4 Agendia Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.7.5 Agendia Recent Developments

7.8 Qiagen

7.8.1 Qiagen Profile

7.8.2 Qiagen Main Business

7.8.3 Qiagen Companion Diagnostics Products, Services and Solutions

7.8.4 Qiagen Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.8.5 Qiagen Recent Developments

7.9 Genomic Health

7.9.1 Genomic Health Profile

7.9.2 Genomic Health Main Business

7.9.3 Genomic Health Companion Diagnostics Products, Services and Solutions

7.9.4 Genomic Health Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.9.5 Genomic Health Recent Developments

7.10 Myriad Genetics

7.10.1 Myriad Genetics Profile

7.10.2 Myriad Genetics Main Business

7.10.3 Myriad Genetics Companion Diagnostics Products, Services and Solutions

7.10.4 Myriad Genetics Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.10.5 Myriad Genetics Recent Developments

7.11 Advanced Cell Diagnostics

7.11.1 Advanced Cell Diagnostics Profile

7.11.2 Advanced Cell Diagnostics Main Business

7.11.3 Advanced Cell Diagnostics Companion Diagnostics Products, Services and Solutions

7.11.4 Advanced Cell Diagnostics Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.11.5 Advanced Cell Diagnostics Recent Developments

7.12 Danaher

7.12.1 Danaher Profile

7.12.2 Danaher Main Business

7.12.3 Danaher Companion Diagnostics Products, Services and Solutions

7.12.4 Danaher Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.12.5 Danaher Recent Developments

7.13 Applied Proteomics

7.13.1 Applied Proteomics Profile

7.13.2 Applied Proteomics Main Business

7.13.3 Applied Proteomics Companion Diagnostics Products, Services and Solutions

7.13.4 Applied Proteomics Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.13.5 Applied Proteomics Recent Developments

8 Industry Chain Analysis

8.1 Companion Diagnostics Industrial Chain

8.2 Companion Diagnostics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Companion Diagnostics Sales Model

8.5.2 Sales Channel

8.5.3 Companion Diagnostics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Roche Holdings

Abbott Laboratories

Thermo Fisher Scientific

Advanced Cell Diagnostics

Danaher

Applied Proteomics

Life Technologies

List of Tables

Table 1. Companion Diagnostics Market Trends

Table 2. Companion Diagnostics Market Drivers & Opportunity

Table 3. Companion Diagnostics Market Challenges

Table 4. Companion Diagnostics Market Restraints

Table 5. Global Companion Diagnostics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Companion Diagnostics Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Companion Diagnostics Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Companion Diagnostics Product Type

Table 9. Key Companies Time to Begin Mass Production of Companion Diagnostics

Table 10. Global Companion Diagnostics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Companion Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Companion Diagnostics Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Companion Diagnostics Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Companion Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Companion Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Companion Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Companion Diagnostics Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Companion Diagnostics Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Companion Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Companion Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Companion Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Companion Diagnostics Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Companion Diagnostics Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Companion Diagnostics Sales Value by Region (2019-2024) & (%)

Table 27. Global Companion Diagnostics Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Companion Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Companion Diagnostics Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Companion Diagnostics Sales Value, (2025-2030) & (US$ Million)

Table 31. Roche Holdings Basic Information List

Table 32. Roche Holdings Description and Business Overview

Table 33. Roche Holdings Companion Diagnostics Products, Services and Solutions

Table 34. Revenue (US$ Million) in Companion Diagnostics Business of Roche Holdings (2019-2024)

Table 35. Roche Holdings Recent Developments

Table 36. Abbott Laboratories Basic Information List

Table 37. Abbott Laboratories Description and Business Overview

Table 38. Abbott Laboratories Companion Diagnostics Products, Services and Solutions

Table 39. Revenue (US$ Million) in Companion Diagnostics Business of Abbott Laboratories (2019-2024)

Table 40. Abbott Laboratories Recent Developments

Table 41. Thermo Fisher Scientific Basic Information List

Table 42. Thermo Fisher Scientific Description and Business Overview

Table 43. Thermo Fisher Scientific Companion Diagnostics Products, Services and Solutions

Table 44. Revenue (US$ Million) in Companion Diagnostics Business of Thermo Fisher Scientific (2019-2024)

Table 45. Thermo Fisher Scientific Recent Developments

Table 46. Agilent Technologies Basic Information List

Table 47. Agilent Technologies Description and Business Overview

Table 48. Agilent Technologies Companion Diagnostics Products, Services and Solutions

Table 49. Revenue (US$ Million) in Companion Diagnostics Business of Agilent Technologies (2019-2024)

Table 50. Agilent Technologies Recent Developments

Table 51. Life Technologies Basic Information List

Table 52. Life Technologies Description and Business Overview

Table 53. Life Technologies Companion Diagnostics Products, Services and Solutions

Table 54. Revenue (US$ Million) in Companion Diagnostics Business of Life Technologies (2019-2024)

Table 55. Life Technologies Recent Developments

Table 56. GE Healthcare Basic Information List

Table 57. GE Healthcare Description and Business Overview

Table 58. GE Healthcare Companion Diagnostics Products, Services and Solutions

Table 59. Revenue (US$ Million) in Companion Diagnostics Business of GE Healthcare (2019-2024)

Table 60. GE Healthcare Recent Developments

Table 61. Agendia Basic Information List

Table 62. Agendia Description and Business Overview

Table 63. Agendia Companion Diagnostics Products, Services and Solutions

Table 64. Revenue (US$ Million) in Companion Diagnostics Business of Agendia (2019-2024)

Table 65. Agendia Recent Developments

Table 66. Qiagen Basic Information List

Table 67. Qiagen Description and Business Overview

Table 68. Qiagen Companion Diagnostics Products, Services and Solutions

Table 69. Revenue (US$ Million) in Companion Diagnostics Business of Qiagen (2019-2024)

Table 70. Qiagen Recent Developments

Table 71. Genomic Health Basic Information List

Table 72. Genomic Health Description and Business Overview

Table 73. Genomic Health Companion Diagnostics Products, Services and Solutions

Table 74. Revenue (US$ Million) in Companion Diagnostics Business of Genomic Health (2019-2024)

Table 75. Genomic Health Recent Developments

Table 76. Myriad Genetics Basic Information List

Table 77. Myriad Genetics Description and Business Overview

Table 78. Myriad Genetics Companion Diagnostics Products, Services and Solutions

Table 79. Revenue (US$ Million) in Companion Diagnostics Business of Myriad Genetics (2019-2024)

Table 80. Myriad Genetics Recent Developments

Table 81. Advanced Cell Diagnostics Basic Information List

Table 82. Advanced Cell Diagnostics Description and Business Overview

Table 83. Advanced Cell Diagnostics Companion Diagnostics Products, Services and Solutions

Table 84. Revenue (US$ Million) in Companion Diagnostics Business of Advanced Cell Diagnostics (2019-2024)

Table 85. Advanced Cell Diagnostics Recent Developments

Table 86. Danaher Basic Information List

Table 87. Danaher Description and Business Overview

Table 88. Danaher Companion Diagnostics Products, Services and Solutions

Table 89. Revenue (US$ Million) in Companion Diagnostics Business of Danaher (2019-2024)

Table 90. Danaher Recent Developments

Table 91. Applied Proteomics Basic Information List

Table 92. Applied Proteomics Description and Business Overview

Table 93. Applied Proteomics Companion Diagnostics Products, Services and Solutions

Table 94. Revenue (US$ Million) in Companion Diagnostics Business of Applied Proteomics (2019-2024)

Table 95. Applied Proteomics Recent Developments

Table 96. Key Raw Materials Lists

Table 97. Raw Materials Key Suppliers Lists

Table 98. Companion Diagnostics Downstream Customers

Table 99. Companion Diagnostics Distributors List

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Companion Diagnostics Product Picture

Figure 2. Global Companion Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Companion Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 4. Companion Diagnostics Report Years Considered

Figure 5. Global Companion Diagnostics Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Companion Diagnostics Revenue in 2023

Figure 7. Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Polymerase Chain Reaction (PCR) Picture

Figure 9. Immunohistochemistry (IHC) Picture

Figure 10. In Situ Hybridization (ISH) Picture

Figure 11. Next Generation Sequencing (NGS) Picture

Figure 12. Global Companion Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global Companion Diagnostics Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Hospitals

Figure 15. Product Picture of Pharmaceutical Companies

Figure 16. Product Picture of Laboratories

Figure 17. Product Picture of Other

Figure 18. Global Companion Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global Companion Diagnostics Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America Companion Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 21. North America Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe Companion Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 23. Europe Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific Companion Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 25. Asia Pacific Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 26. South America Companion Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 27. South America Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa Companion Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions Companion Diagnostics Sales Value (%), (2019-2030)

Figure 31. United States Companion Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 33. United States Companion Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe Companion Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe Companion Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 37. China Companion Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 38. China Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 39. China Companion Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan Companion Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan Companion Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea Companion Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea Companion Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia Companion Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia Companion Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 49. India Companion Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 50. India Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 51. India Companion Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 52. Companion Diagnostics Industrial Chain

Figure 53. Companion Diagnostics Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions